AzTrials
AzTrials

Fluid ResponsivenessNCT06087250

Carotid Artery Corrected Flow Time and Fluid Responsiveness in Geriatric Patients

An observational study of Fluid Responsiveness and Common Carotid Artery, run by Marmara University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Carotid blood flow and corrected carotid flow time (Carotid Flow Time (FTc)) provide information about left ventricular preload and inversely correlate with systemic vascular resistance. The reliability in assessing fluid responsiveness has been demonstrated in studies involving invasive cardiac output measurements. Read more about this study

Who is it for?
Ages 65 to 100 years
Conditions the study is for
Fluid Responsiveness, Common Carotid Artery
Type of treatment
Injection or infusion
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Aug 2023to 24 Oct 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 100 years
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: geriatric patient (older than 65 years of age) having surgery under general anesthesia

Who may be able to join

  • geriatric patient (older than 65 years of age) having surgery under general anesthesia

Who cannot join

  • Common carotid artery stenosis, common carotid artery disease

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Marmara University Hospital

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: Reliability of Carotid Artery Corrected Flow Time Predicting Fluid Responsiveness in Geriatric Patients.

Carotid blood flow and corrected carotid flow time (Carotid Flow Time (FTc)) provide information about left ventricular preload and inversely correlate with systemic vascular resistance. The reliability in assessing fluid responsiveness has been demonstrated in studies involving invasive cardiac output measurements. In the elderly patient population where arterial elasticity can be compromised, there is no existing data in literature that determines the reliability and predictive value of FTc after general anesthesia induction.

Read the detailed description

Doppler ultrasound of the common carotid artery has begun to be used as a potential non-invasive tool for assessing hemodynamic status. Its non-invasive nature, ability to be applied independently of the patient's position, ease of application due to the superficial location of the carotid artery, and resistance to intrathoracic pressure changes are among its advantages. Carotid blood flow and corrected carotid flow time (Carotid Flow Time (FTc)) provide information about left ventricular preload and inversely correlate with systemic vascular resistance. Additionally, the velocity time integral (VTI) measuring blood flow through the carotid artery during systole, when multiplied by the cross-sectional area of the carotid artery, allows for the determination of flow within the carotid artery. The reliability in assessing fluid responsiveness has been demonstrated in studies involving invasive cardiac output measurements. In the elderly patient population where arterial elasticity can be compromised, there is no existing data in literature that determines the reliability and predictive value of FTc after general anesthesia induction.

Keywords
fluid responsiveness, carotid blood flow, carotid corrected flow time

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06087250
Study groupRoleWhat they receive
Fluid responsiveA 15% increase in cardiac output following a fluid challenge ( 6ml/kg crystalloid solution infusion in 30 min). Carotid corrected flow time measured before and after fluid challenge by ultrasound.
Fluid non-responsiveFailure of 15% increase in cardiac output following a fluid challenge ( 6ml/kg crystalloid solution infusion in 30 min). Carotid corrected flow time measured before and after fluid challenge by ultrasound.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. carotid corrected flow time (cFT)

    the ability ofc FT to predict fluid responsiveness

    Measured: 1 hour

Secondary outcomes (1)
  1. cutt-of value of cFT

    the cutt-of value of cFT to predict fluid responsiveness

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Oct 2023
  2. Study start1 Aug 2023
  3. Primary completion24 Oct 2023
  4. Study completion24 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case crossover
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06087250
Sponsor's protocol ID
2023
Status last verified
Apr 2024
First submitted
12 Oct 2023
Last updated
2 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Fluid Responsiveness and Common Carotid Artery, run by Marmara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

carotid corrected flow time (cFT) (time frame: 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in